Table 2. Univariate analysis of PFS and OS.
| Factors | PFS (months) | p-value | OS (months) | p-value |
|---|---|---|---|---|
| ECOG PS (1 versus 2 versus 3) |
25.9 versus 7.5 versus 4.9 | 0.015 | 27 versus NR versus 13 | 0.416 |
| Site of metastases (Bone only versus Nodal/visceral) |
7.7 versus 9.1 | 0.690 | 28.7 versus 27.3 | 0.570 |
| Prior docetaxel (yes versus no) | 7.4 versus 8.2 | 0.459 | 27.5 versus NR | 0.622 |
| Prior abiraterone acetate (yes versus no) | 11 versus 7 | 0.060 | 28.7 versus 15 | <0.001 |
| PSA response | 12 versus 5 | 0.001 | NR versus 21 | 0.027 |